Hedge Fund - Opaleye Management
Crinetics Pharmaceuticals Inc. (CRNX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q2 (2024-06-30) | $0 | 0% | 0 | $46.18 |
| 2 | 2024 - Q1 (2024-03-31) | $9,830,100 | 2.14% | 210,000 | $39.13 |
| 3 | 2023 - Q4 (2023-12-31) | $10,940,850 | 2.9% | 307,500 | $30.67 |
| 4 | 2023 - Q3 (2023-09-30) | $11,003,800 | 3.57% | 370,000 | $20.61 |
| 5 | 2023 - Q2 (2023-06-30) | $15,226,900 | 3.64% | 845,000 | $19.94 |
| 6 | 2023 - Q1 (2023-03-31) | $12,622,742 | 3.78% | 785,794 | $18.51 |
| 7 | 2022 - Q4 (2022-12-31) | $13,395,600 | 4.65% | 732,000 | $17.62 |
| 8 | 2022 - Q3 (2022-09-30) | $13,184,000 | 5.44% | 671,300 | $20.39 |
| 9 | 2022 - Q2 (2022-06-30) | $12,520,000 | 5.64% | 671,300 | $19.96 |
| 10 | 2022 - Q1 (2022-03-31) | $15,211,000 | 4.72% | 693,000 | $20.24 |
| 11 | 2021 - Q4 (2021-12-31) | $20,580,000 | 4.36% | 724,400 | $24.65 |
| 12 | 2021 - Q3 (2021-09-30) | $8,464,000 | 1.58% | 402,113 | $20.92 |
| 13 | 2021 - Q2 (2021-06-30) | $3,779,000 | 0.62% | 200,500 | $17.57 |
| 14 | 2021 - Q1 (2021-03-31) | $2,873,000 | 0.42% | 188,000 | $15.50 |
| 15 | 2020 - Q4 (2020-12-31) | $0 | 0% | 0 | $13.93 |
| 16 | 2020 - Q3 (2020-09-30) | $3,761,000 | 0.73% | 240,000 | $15.29 |
| 17 | 2020 - Q2 (2020-06-30) | $7,625,000 | 1.53% | 435,200 | $17.05 |
| 18 | 2020 - Q1 (2020-03-31) | $5,421,000 | 1.43% | 368,750 | $20.50 |
| 19 | 2019 - Q4 (2019-12-31) | $6,676,000 | 1.3% | 266,100 | $19.04 |
| 20 | 2019 - Q3 (2019-09-30) | $3,113,000 | 1.12% | 207,000 | $19.45 |
| 21 | 2019 - Q2 (2019-06-30) | $900,000 | 0.27% | 36,000 | $24.76 |
| 22 | 2019 - Q1 (2019-03-31) | $1,661,000 | 0.45% | 73,000 | $24.58 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center